185 related articles for article (PubMed ID: 30400014)
1. Gut carbohydrate inhibits GIP secretion via a microbiota/SCFA/FFAR3 pathway.
Lee EY; Zhang X; Miyamoto J; Kimura I; Taknaka T; Furusawa K; Jomori T; Fujimoto K; Uematsu S; Miki T
J Endocrinol; 2018 Dec; 239(3):267-276. PubMed ID: 30400014
[TBL] [Abstract][Full Text] [Related]
2. Phloretin suppresses carbohydrate-induced GLP-1 secretion via inhibiting short chain fatty acid release from gut microbiome.
Ma Y; Lee E; Yoshikawa H; Noda T; Miyamoto J; Kimura I; Hatano R; Miki T
Biochem Biophys Res Commun; 2022 Sep; 621():176-182. PubMed ID: 35841764
[TBL] [Abstract][Full Text] [Related]
3. Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion.
Lee EY; Kaneko S; Jutabha P; Zhang X; Seino S; Jomori T; Anzai N; Miki T
J Endocrinol; 2015 Mar; 224(3):205-14. PubMed ID: 25486965
[TBL] [Abstract][Full Text] [Related]
4. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon.
Christiansen CB; Gabe MBN; Svendsen B; Dragsted LO; Rosenkilde MM; Holst JJ
Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G53-G65. PubMed ID: 29494208
[TBL] [Abstract][Full Text] [Related]
5. Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men.
Aoki K; Miyazaki T; Nagakura J; Orime K; Togashi Y; Terauchi Y
Endocr J; 2010; 57(8):673-7. PubMed ID: 20519807
[TBL] [Abstract][Full Text] [Related]
6. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms.
Lin HV; Frassetto A; Kowalik EJ; Nawrocki AR; Lu MM; Kosinski JR; Hubert JA; Szeto D; Yao X; Forrest G; Marsh DJ
PLoS One; 2012; 7(4):e35240. PubMed ID: 22506074
[TBL] [Abstract][Full Text] [Related]
7. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Hira T; Koga T; Sasaki K; Hara H
Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
[TBL] [Abstract][Full Text] [Related]
8. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids.
Ducastel S; Touche V; Trabelsi MS; Boulinguiez A; Butruille L; Nawrot M; Peschard S; Chávez-Talavera O; Dorchies E; Vallez E; Annicotte JS; Lancel S; Briand O; Bantubungi K; Caron S; Bindels LB; Delzenne NM; Tailleux A; Staels B; Lestavel S
Sci Rep; 2020 Jan; 10(1):174. PubMed ID: 31932631
[TBL] [Abstract][Full Text] [Related]
9. Novel extrapancreatic effects of incretin.
Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
[TBL] [Abstract][Full Text] [Related]
10. Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model.
Kishida Y; Okubo H; Ohno H; Oki K; Yoneda M
J Gastroenterol; 2017 Nov; 52(11):1180-1191. PubMed ID: 28349245
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
Pathak V; Vasu S; Flatt PR; Irwin N
Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
[TBL] [Abstract][Full Text] [Related]
12. Diet-Induced Obese Mice and Leptin-Deficient
Lee E; Miedzybrodzka EL; Zhang X; Hatano R; Miyamoto J; Kimura I; Fujimoto K; Uematsu S; Rodriguez-Cuenca S; Vidal-Puig A; Gribble FM; Reimann F; Miki T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509948
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
Seino Y; Maekawa R; Ogata H; Hayashi Y
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):27-32. PubMed ID: 27186352
[TBL] [Abstract][Full Text] [Related]
14. Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH) -.
Hiki M; Shimada K; Kiyanagi T; Fukao K; Hirose K; Ohsaka H; Fukushima Y; Kume A; Matsumori R; Sumiyoshi K; Miyazaki T; Ohmura H; Kurata T; Miida T; Daida H
Circ J; 2010 Jul; 74(7):1471-8. PubMed ID: 20519875
[TBL] [Abstract][Full Text] [Related]
15. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.
Moriya R; Shirakura T; Ito J; Mashiko S; Seo T
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1358-65. PubMed ID: 19808907
[TBL] [Abstract][Full Text] [Related]
16. Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin.
Osonoi T; Saito M; Hariya N; Goto M; Mochizuki K
Peptides; 2016 Dec; 86():118-125. PubMed ID: 27780736
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients.
Narita T; Yokoyama H; Yamashita R; Sato T; Hosoba M; Morii T; Fujita H; Tsukiyama K; Yamada Y
Diabetes Obes Metab; 2012 Mar; 14(3):283-7. PubMed ID: 22051162
[TBL] [Abstract][Full Text] [Related]
18. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice.
Shimotoyodome A; Fukuoka D; Suzuki J; Fujii Y; Mizuno T; Meguro S; Tokimitsu I; Hase T
Endocrinology; 2009 May; 150(5):2118-26. PubMed ID: 19179446
[TBL] [Abstract][Full Text] [Related]
19. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes.
Nøhr MK; Pedersen MH; Gille A; Egerod KL; Engelstoft MS; Husted AS; Sichlau RM; Grunddal KV; Poulsen SS; Han S; Jones RM; Offermanns S; Schwartz TW
Endocrinology; 2013 Oct; 154(10):3552-64. PubMed ID: 23885020
[TBL] [Abstract][Full Text] [Related]
20. Incretin hormones, obesity and gut microbiota.
Angelini G; Russo S; Mingrone G
Peptides; 2024 Aug; 178():171216. PubMed ID: 38636809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
